These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 30898821)

  • 21. Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: a protocol for a randomised, double-blind, placebo-controlled trial.
    Nørgaard-Pedersen C; Nielsen K; Steffensen R; Eriksen L; Jørgensen MM; Kesmodel US; Christiansen OB
    BMJ Open; 2022 Sep; 12(9):e064780. PubMed ID: 36137638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials.
    Areia AL; Fonseca E; Areia M; Moura P
    Arch Gynecol Obstet; 2016 Jan; 293(1):81-86. PubMed ID: 26059084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of hydroxychloroquine on thrombosis prevention and antiphospholipid antibody levels in primary antiphospholipid syndrome: A pilot open label randomized prospective study.
    Kravvariti E; Koutsogianni A; Samoli E; Sfikakis PP; Tektonidou MG
    Autoimmun Rev; 2020 Apr; 19(4):102491. PubMed ID: 32084592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acetylsalicylic acid does not prevent first-trimester unexplained recurrent pregnancy loss: A randomized controlled trial.
    Blomqvist L; Hellgren M; Strandell A
    Acta Obstet Gynecol Scand; 2018 Nov; 97(11):1365-1372. PubMed ID: 29972884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of hydroxychloroquine on antiphospholipid antibodies-inhibited endometrial angiogenesis.
    Dong Y; Lu Y; Xia Y; Wang X
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7084-7092. PubMed ID: 34182874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Higher levels of procoagulant microparticles in women with recurrent miscarriage are not associated with antiphospholipid antibodies.
    Martínez-Zamora MA; Tàssies D; Creus M; Reverter JC; Puerto B; Monteagudo J; Carmona F; Balasch J
    Hum Reprod; 2016 Jan; 31(1):46-52. PubMed ID: 26534898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous immunoglobulin treatment for secondary recurrent miscarriage: a randomised, double-blind, placebo-controlled trial.
    Christiansen OB; Larsen EC; Egerup P; Lunoee L; Egestad L; Nielsen HS
    BJOG; 2015 Mar; 122(4):500-8. PubMed ID: 25412569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A three-arm, multicenter, open-label randomized controlled trial of hydroxychloroquine and low-dose prednisone to treat recurrent pregnancy loss in women with undifferentiated connective tissue diseases: protocol for the Immunosuppressant regimens for LIving FEtuses (ILIFE) trial.
    Yang S; Ni R; Lu Y; Wang S; Xie F; Zhang C; Lu L
    Trials; 2020 Sep; 21(1):771. PubMed ID: 32907619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxychloroquine in lupus pregnancy.
    Clowse ME; Magder L; Witter F; Petri M
    Arthritis Rheum; 2006 Nov; 54(11):3640-7. PubMed ID: 17075810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
    Brenner B; Hoffman R; Blumenfeld Z; Weiner Z; Younis JS
    Thromb Haemost; 2000 May; 83(5):693-7. PubMed ID: 10823264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome.
    Di Nisio M; Peters L; Middeldorp S
    Cochrane Database Syst Rev; 2005 Apr; (2):CD004734. PubMed ID: 15846729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous immunoglobulin in the prevention of recurrent miscarriage: does it work?
    Christiansen OB; Nielsen HS
    Chem Immunol Allergy; 2005; 88():117-127. PubMed ID: 16129941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial.
    Scarpellini F; Sbracia M
    Hum Reprod; 2009 Nov; 24(11):2703-8. PubMed ID: 19617208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of hydroxychloroquine on antiphospholipid antibody-induced changes in first trimester trophoblast function.
    Albert CR; Schlesinger WJ; Viall CA; Mulla MJ; Brosens JJ; Chamley LW; Abrahams VM
    Am J Reprod Immunol; 2014 Feb; 71(2):154-64. PubMed ID: 24325143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies).
    Rai R; Cohen H; Dave M; Regan L
    BMJ; 1997 Jan; 314(7076):253-7. PubMed ID: 9022487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss: a multicenter trial with a minimization randomization scheme.
    Schleussner E; Kamin G; Seliger G; Rogenhofer N; Ebner S; Toth B; Schenk M; Henes M; Bohlmann MK; Fischer T; Brosteanu O; Bauersachs R; Petroff D;
    Ann Intern Med; 2015 May; 162(9):601-9. PubMed ID: 25938990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidiabetogenic effects of hydroxychloroquine on insulin sensitivity and beta cell function: a randomised trial.
    Wasko MC; McClure CK; Kelsey SF; Huber K; Orchard T; Toledo FG
    Diabetologia; 2015 Oct; 58(10):2336-43. PubMed ID: 26197707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study.
    Levy RA; Vilela VS; Cataldo MJ; Ramos RC; Duarte JL; Tura BR; Albuquerque EM; Jesús NR
    Lupus; 2001; 10(6):401-4. PubMed ID: 11434574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.
    Laskin CA; Spitzer KA; Clark CA; Crowther MR; Ginsberg JS; Hawker GA; Kingdom JC; Barrett J; Gent M
    J Rheumatol; 2009 Feb; 36(2):279-87. PubMed ID: 19208560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction.
    Nagels HE; Rishworth JR; Siristatidis CS; Kroon B
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009749. PubMed ID: 26608695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.